跳至主要内容
临床试验/NCT01509495
NCT01509495终止1 期

Impedance Measurements in Heart Failure Patients

Medtronic BRC6 个研究点 分布在 4 个国家目标入组 20 人开始时间: 2011年12月1日最近更新:
适应症

试验速览

阶段
1 期
状态
终止
发起方
入组人数
20
试验地点
6
主要终点
Impedance Measurement of Patients in Heart Failure, impedance change first to last measurement

研究概览

简要总结

The purpose of this study is to measure impedance during inpatient treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients admitted to hospital for symptoms of congestive heart failure
  • patients older than 18 years
  • patients willing and able to give informed consent

排除标准

  • patients who will require adrenergic or positive inotropic medications
  • patients enrolled in a concurrent study that may confound the results of this study
  • patients unable or unwilling to participate in study procedures
  • patients who are pregnant
  • patients who are mentally handicapped or legal incompetent
  • patients who are dependent on investigator or sponsor

结局指标

主要结局

Impedance Measurement of Patients in Heart Failure, impedance change first to last measurement

时间窗: every 4 hours up to 48 hours

次要结局

  • Correlation between hemodynamic (central venous or arterial pressure) and impedance measurements (optional)(every 4 hours up to 48 hours)
  • Accuracy of Respiratory rate determined by impedance measurements(every 4 hours up to 48 hours)

研究者

发起方
Medtronic BRC
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Impedance Measurements in Heart Failure Patients | 临床试验